The Entry Lag of Innovative Drugs in Russia, 2010–2019

Objective: Evaluation of the lag timelines for the launch of innovative drugs to the Russian market and pharmacoeconomic factors they can depend on. Methods: To complete the investigation, we used information about drug products, namely, dates of submission and approval, and pharmacological groups r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaplenko, Alexander, Gildeeva, Geliya, Vlassov, Vasiliy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151232/
https://www.ncbi.nlm.nih.gov/pubmed/34064608
http://dx.doi.org/10.3390/ijerph18105052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151232/
https://www.ncbi.nlm.nih.gov/pubmed/34064608
http://dx.doi.org/10.3390/ijerph18105052

Ejemplares similares